Thorgate
Start free trial
Trademark owner · USPTO register · rebuilt nightly

Regeneron Pharmaceuticals, Inc.

288 live US trademarks, filing since 1990. The 14th largest trademark holder in Class 5 (pharmaceuticals). 107 new applications filed this year.

Get alerts when they file Check a name against the register
Live marks
288
registered + pending
Registered
73
on the Principal Register
Pending
215
applications in progress
Filed in 2026
107
1 intent to use
Classes used
11
of 45 Nice classes
First filing
1990
36 years on the register
At a glanceplain-language reads of the register
Mostly pharmaceuticals: 222 of 288 live marks are in Class 5. Science & technology (SaaS) (Class 42) is next with 31.
Filing faster than usual: 107 applications so far in 2026 against a yearly average of 13.8.
New products ahead: 1 of the 107 filings this year are intent-to-use applications, meaning the goods are not yet on sale.
8 registrations have a maintenance filing due in the next 12 months, 1 already in the grace period.
Filing activityapplications per year, by filing date
0 107 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 107 so far

Marks held on the register, by filing date. 2026 is year to date.

Portfolio by classlive marks · rank among filers in that class

A multi-class mark counts once per class. Rank shown where the owner is in the class's top 50.

Latest activity

What Regeneron Pharmaceuticals, Inc. filed most recently.

MarkClassFiledBasisStatusSerial
BYRTREYA 5 Oct 6, 2026 — pending 50146185
DAYVELTRI 5 Oct 6, 2026 — pending 50146331
DAZVELTRI 5 Oct 6, 2026 — pending 50146340
GEMDAYLA 5 Oct 6, 2026 — pending 50146370
GOVEYZA 5 Oct 6, 2026 — pending 50146377
MIBURKI 5 Oct 6, 2026 — pending 50147119
MYBURKI 5 Oct 6, 2026 — pending 50147129
NUSILVA 5 Oct 6, 2026 — pending 50147136
QYTREE 5 Oct 6, 2026 — pending 50147142
VELBIRTRY 5 Oct 6, 2026 — pending 50147154
Recently registeredlast 12 months
PASATRU · Cl. 5 · Reg. 8,513,797
Oct 20, 2026
REGENERON · Cl. 5 · Reg. 8,504,724
Oct 13, 2026
MY EVKEEZA DROP · Cl. 44 · Reg. 8,487,438
Oct 6, 2026
MY EVKEEZA DROP · Cl. 44 · Reg. 8,471,435
Sep 29, 2026
Y · Cl. 16, 35, 44 · Reg. 8,392,858
Aug 11, 2026
OTARMENI · Cl. 5 · Reg. 8,394,767
Aug 11, 2026
M · Cl. 5 · Reg. 8,188,282
Mar 24, 2026
LYNOZYFIC · Cl. 5 · Reg. 8,178,821
Mar 17, 2026

Registration starts the maintenance clock: a Section 8 declaration is due between years 5 and 6.

Maintenance windows aheadnext 12 months · from registration dates
LOOK TO YOUR FUTURE · Reg. 6,153,251 · registered Sep 2020
Section 8 declaration (years 5–6) · in grace period until Mar 15, 2027
Sep 15, 2025 → Sep 15, 2026
LIBTAYO · Reg. 6,217,234 · registered Dec 2020
Section 8 declaration (years 5–6)
Dec 8, 2025 → Dec 8, 2026
LIBTAYO · Reg. 6,217,235 · registered Dec 2020
Section 8 declaration (years 5–6)
Dec 8, 2025 → Dec 8, 2026
REGENERON · Reg. 5,167,999 · registered Mar 2017
Section 8 & 9 renewal (year 10)
Mar 21, 2026 → Mar 21, 2027
EVKEEZA · Reg. 6,329,637 · registered Apr 2021
Section 8 declaration (years 5–6)
Apr 20, 2026 → Apr 20, 2027
REGENERON GENETICS CENTER · Reg. 5,200,549 · registered May 2017
Section 8 & 9 renewal (year 10)
May 9, 2026 → May 9, 2027
REGENERON GENETICS CENTER · Reg. 5,200,550 · registered May 2017
Section 8 & 9 renewal (year 10)
May 9, 2026 → May 9, 2027
REGENERON · Reg. 6,430,157 · registered Jul 2021
Section 8 declaration (years 5–6)
Jul 20, 2026 → Jul 20, 2027

A filing missed by the due date enters a six-month grace period, then the registration cancels.

Other large filers in Class 5Full ranking →
Glaxo Group Limited 1,068 live
Novartis AG 964 live
Kenvue Inc. 674 live
Common questions

About Regeneron Pharmaceuticals, Inc. trademarks.

How many trademarks does Regeneron Pharmaceuticals, Inc. have?

288 live US trademarks as of October 23, 2026: 73 registered and 215 pending applications. 107 were filed in 2026 so far.

What does Regeneron Pharmaceuticals, Inc. sell, according to its trademarks?

Mostly pharmaceuticals (Class 5, 222 live marks). Also science & technology (saas) (Class 42) and medical & beauty services (Class 44).

Who owns the REGENERON trademark?

REGENERON is owned by Regeneron Pharmaceuticals, Inc.. It was registered on August 20, 1991 (Reg. No. 1654595) and is live. The same owner holds 287 other live US marks.

When did Regeneron Pharmaceuticals, Inc. first file a trademark?

Its oldest live US filing dates from 1990: REGENERON, filed August 16, 1990.

Know the morning after Regeneron Pharmaceuticals, Inc. files.

Watch this company in Thorgate and get an alert for every new application, registration, publication and lapse, with the opposition deadline already worked out. Or monitor your own marks for conflicts with theirs.

Watch this owner Monitor my marks

Data: USPTO trademark bulk files, processed nightly by Thorgate. Last rebuilt October 23, 2026. Counts cover the US federal register only, not state or foreign marks. Owner names are shown as recorded by the USPTO. This page reports public-record facts and dates and is not legal advice. For the official record of any mark, follow its serial number to USPTO TSDR.